"This is the first GLP-1 receptor agonists study to show significant reduction in the risk of kidney failure…Our study establishes GLP-1 receptor agonists as an important kidney-protective class of ...

Addiction, a chronic mental health condition, affects millions of Americans, and traditional treatments have often fallen short of providing lasting relief. However, a new class of medications, GLP-1 ...

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...

—Study findings highlight the need for improved recommendations of guideline-directed therapies and support the consideration of dual therapy in appropriately selected high-risk patients. In a study ...

Please provide your email address to receive an email when new articles are posted on . A link was found between GLP-1 receptor agonist use in PAH and significant decreases in mortality, respiratory ...